BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement Post published:September 5, 2023 Post category:Press Release
Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing Post published:September 5, 2023 Post category:Press Release
California Psychedelic Decriminalisation Bill Clears Appropriations Committee with Amendments Post published:September 1, 2023 Post category:News
Natural Medicine Advisory Bulletin #3: August 2023 Post published:September 1, 2023 Post category:Colorado Natural Medicine Advisory Bulletin
Psychedelic Bulletin #144: Otsuka to Buy Mindset; Responses to FDA Draft Guidance; Cybin to Acquire Small Pharma; Usona Publishes Phase 2 Study Post published:August 31, 2023 Post category:Psychedelic Bulletin
FILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA Post published:August 31, 2023 Post category:Press Release
BREAKING: Big Pharma Company Otsuka to Acquire Mindset Pharma for CAD $80m Post published:August 31, 2023 Post category:News
COMPASS Pathways to participate in upcoming September investor conferences Post published:August 29, 2023 Post category:Press Release
Cybin Set to Acquire British DMT Drug Developer Small Pharma Post published:August 28, 2023 Post category:News
Sunstone Therapies in Collaboration with the University of Vermont Announces Publication of Study Showing Feasibility of Direct Observation of Therapeutic Connection in Psilocybin-Assisted Therapy Post published:August 25, 2023 Post category:Press Release